Boston Scientific acquires California company valued at $900M

Boston Scientific acquires California company valued at $900M

The Marlborough device maker is paying $443 million upfront, plus up to $221 million in possible milestones, to buy the remainder of a company in which it already owned a major stake.

Boston Scientific Surges Into Buy Zone On $900 Million Takeover Of Bolt Medical

Boston Scientific stock popped Wednesday after the medtech giant agreed to full acquire Bolt Medical for up to $900 million. The post Boston Scientific Surges Into Buy Zone On $900 Million Takeover Of Bolt Medical appeared first on Investor's Business Daily.

Boston Scientific to acquire remaining ownership stake in Bolt Medical for $664m

Boston Scientific Corporation has entered into a definitive agreement to acquire the remaining 74% stake in Bolt Medical at $664m.The post Boston Scientific to acquire remaining ownership stake in Bolt Medical for $664m appeared first on Medical Device Network.

Boston Scientific enters IVL arms race with acquisition worth up to $664M

Boston Scientific has agreed to acquire Bolt Medical, a California-based medical device company focused on developing new intravascular lithotripsy technologies. The news comes less than one year after Johnson & Johnson acquired IVL pioneers Shockwave Medical for $13 billion.

Boston Scientific Announces Acquisition Agreement for Bolt Medical - Cardiac Interventions Today

January 8, 2025—Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) laser-based platform for the treatment of coronary and peripheral artery disease (PAD). Boston Scientific anticipates the transaction to be completed in the first half of 2025, subject to customary closing conditions. Boston Scientific stated that it initially develo…

Boston Scientific Announces Acquisition Agreement for Bolt Medical - Endovascular Today

January 8, 2025—Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) laser-based platform for the treatment of coronary and peripheral artery disease (PAD). Boston Scientific anticipates the transaction to be completed in the first half of 2025, subject to customary closing conditions. Boston Scientific stated that it initially develo…